Supernus Pharmaceuticals $450 million acquisition of Adamas Pharmaceuticals
We are advising Lazard as financial adviser to Adamas
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Manchester United secondary offering
We advised the underwriter on the SEC-registered stock offering
Enphys Acquisition Corp. $345 million IPO
We advised the underwriters on the SPAC IPO and NYSE listing
Nuvei $425 million U.S. IPO
We advised Nuvei on its U.S. IPO and Nasdaq listing of subordinate voting shares
XP $9.5 billion combination involving Itaú Unibanco Holding’s XPart unit
We advised XP on the transaction
XP acquisition of a minority stake in Jive Investments
We advised XP on the transaction
Regions Bank acquires Sabal Capital Partners
We are advising Regions on the transaction
AGCO €600 million senior notes offering
We advised the initial purchasers on an unregistered investment-grade euro debt offering
Hennessy Capital Investment VI $300 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
Match Group stock and notes offerings to repurchase exchangeable notes
We advised Match Group on its registered direct and senior notes offerings to repurchase exchangeable notes for $1.5 billion